Mandate

Vinge advises eEducation Albert AB (publ) in connection with the listing on Nasdaq First North Growth Market6 October 2021

Vinge has advised eEducation Albert AB (publ) (”Albert”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 21 September 2021 and the first day of trading occurred on 1 October 2021.

The offer in connection with the listing covered approximately 4 700 000 newly issued shares as well as an oversubscription option for a further total amount of approximately 700 000 shares. The shares were offered at a price of SEK 49 per share, which entails that the offer (in conjunction with full utilization of the oversubscription option) amounted to approximately SEK 264 million. The price corresponds to a market value for the company of approximately SEK 600 million prior to the implementation of the offer.

Albert, which was founded in 2015 and has its registered office in Gothenburg, is an app‑based educational platform for children in the age intervals between 3 and 16 and offers EdTech services on a subscription basis. Since Albert was founded, the company has helped more than 275 000 families with their children’s education.

Vinge’s team primarily consisted of Wibeke Sorling, Edin Agic, Linus Adolfsson, Hanna Jansson (Capital Markets and Public M&A), Anna Backman (Employment), Alexander Lindberg, Anna Högsten (IP/IT), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026